BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, Karkhanis S, Lester W, Roslund N, West R, Wyatt JI, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382-403. [PMID: 32467090 DOI: 10.1136/gutjnl-2020-321299] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Padeniya P, Ediriweera DS, De Silva AP, Niriella MA, Premawardhena A. Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion-dependent beta thalassaemia: a cross-sectional study. BMJ Open 2022;12:e061156. [PMID: 36167380 DOI: 10.1136/bmjopen-2022-061156] [Reference Citation Analysis]
2 Madoff DC, Abi-Jaoudeh N, Braxton D, Goyal L, Jain D, Odisio BC, Salem R, Schattner M, Sheth R, Li D. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. Oncologist 2022:oyac139. [PMID: 35925597 DOI: 10.1093/oncolo/oyac139] [Reference Citation Analysis]
3 Cai X, Gao J, Liu S, Wang M, Hu J, Hong J, Zhu Q, Tuerxun G, Dang Y, Li N, Ashraf G. Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/3150380] [Reference Citation Analysis]
4 Padeniya P, Goonasekara H, Abeysekera G, Jayasekara R, Dissanayake V. Frequency of Hereditary Hemochromatosis Gene (HFE) Variants in Sri Lankan Transfusion-Dependent Beta-Thalassemia Patients and Their Association With the Serum Ferritin Level. Front Pediatr 2022;10:890989. [DOI: 10.3389/fped.2022.890989] [Reference Citation Analysis]
5 Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med 2022. [PMID: 35796150 DOI: 10.1111/joim.13531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Şendur HN, Cerit MN, Ibrahimkhanli N, Şendur AB, Özhan Oktar S. Interobserver Variability in Ultrasound-Based Liver Fat Quantification. J Ultrasound Med 2022. [PMID: 35778902 DOI: 10.1002/jum.16048] [Reference Citation Analysis]
7 Reynard ME, Dufour JF. Elective percutaneous liver biopsy and use of aspirin. United European Gastroenterol J 2022. [PMID: 35652196 DOI: 10.1002/ueg2.12254] [Reference Citation Analysis]
8 Kristensen H, Kimer N, Møller S. Indications and methods for measuring portal hypertension in cirrhosis. Scand J Gastroenterol 2022;:1-9. [PMID: 35514215 DOI: 10.1080/00365521.2022.2065889] [Reference Citation Analysis]
9 Somers N, Vandekerckhove E, Geerts A, Degroote H, Lefere S, Devisscher L, Meuris L, Callewaert N, Van Vlierberghe H, Verhelst X. Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection. Acta Clin Belg 2022;:1-7. [PMID: 35505274 DOI: 10.1080/17843286.2022.2072110] [Reference Citation Analysis]
10 Wang C, Pai AK, Putra J. Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation. J Clin Pathol 2022:jclinpath-2022-208246. [PMID: 35414523 DOI: 10.1136/jclinpath-2022-208246] [Reference Citation Analysis]
11 Wang L, Li B, Hu B, Shen G, Zheng Y, Zheng Y. Failure mode effect and criticality analysis of ultrasound device by classification tracking. BMC Health Serv Res 2022;22:429. [PMID: 35361206 DOI: 10.1186/s12913-022-07843-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Neuberger J. LONG-TERM care of the ADUT liver transplant recipient. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.012] [Reference Citation Analysis]
13 Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Koskinas J, Koullias E, Mitranou A, Manesis E, Zoumpoulis PS. Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment. Ultrasound Q 2022. [PMID: 35353797 DOI: 10.1097/RUQ.0000000000000605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sarvestany SS, Kwong JC, Azhie A, Dong V, Cerocchi O, Ali AF, Karnam RS, Kuriry H, Shengir M, Candido E, Duchen R, Sebastiani G, Patel K, Goldenberg A, Bhat M. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. The Lancet Digital Health 2022;4:e188-99. [DOI: 10.1016/s2589-7500(21)00270-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cheng N, Ren Y, Zhou J, Zhang Y, Wang D, Zhang X, Chen B, Liu F, Lv J, Cao Q, Chen S, Du H, Hui D, Weng Z, Liang Q, Su B, Tang L, Han L, Chen J, Shao C. Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images. Gastroenterology 2022:S0016-5085(22)00155-X. [PMID: 35202643 DOI: 10.1053/j.gastro.2022.02.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Haworth JJ, Pitcher CK, Ferrandino G, Hobson AR, Pappan KL, Lawson JLD. Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath. Crit Rev Clin Lab Sci 2022;:1-20. [PMID: 35188863 DOI: 10.1080/10408363.2022.2038075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cardoso AC, Tovo CV, Leite NC, El Bacha IA, Calçado FL, Coral GP, Sammarco GN, Cravo C, Carvalho Filho RJ, de Mello Perez R, Luiz RR, Parise ER, Villela-nogueira CA. Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease. Dig Dis Sci. [DOI: 10.1007/s10620-021-07363-x] [Reference Citation Analysis]
18 Jiang K, Zhang L, Li J, Hu H, Huang Q, Qiu T, Mo X, Ren J, Guo W, Tao Y, Cui H, Zuo Y, Chen X, Xie Y, Li Y, Liang H, Liu Z, Xie L, Mao R, Jiang Q, Huang K. Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02108-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zeng K, Jiang Z, Yang J, Chen K, Lu Q. Role of endoscopic ultrasound-guided liver biopsy: a Meta-analysis. Scand J Gastroenterol 2022;:1-13. [PMID: 35049405 DOI: 10.1080/00365521.2021.2025420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zherebtsov EA, Potapova EV, Mamoshin AV, Shupletsov VV, Kandurova KY, Dremin VV, Abramov AY, Dunaev AV. Fluorescence lifetime needle optical biopsy discriminates hepatocellular carcinoma. Biomed Opt Express 2022;13:633. [DOI: 10.1364/boe.447687] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Facciorusso A, Crinò SF, Ramai D, Fabbri C, Mangiavillano B, Lisotti A, Muscatiello N, Cotsoglou C, Fusaroli P. Diagnostic yield of endoscopic ultrasound-guided liver biopsy in comparison to percutaneous liver biopsy: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2021;:1-7. [PMID: 34918578 DOI: 10.1080/17474124.2022.2020645] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Hadjittofi C, Feretis M, Martin J, Harper S, Huguet E. Liver regeneration biology: Implications for liver tumour therapies. World J Clin Oncol 2021; 12(12): 1101-1156 [DOI: 10.5306/wjco.v12.i12.1101] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Amodu A, Porteny T, Schmidt IM, Ladin K, Waikar SS. Nephrologists' Attitudes Toward Native Kidney Biopsy: A Qualitative Study. Kidney Med 2021;3:1022-31. [PMID: 34939011 DOI: 10.1016/j.xkme.2021.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Adnan A, Sheth RA. Image-guided Percutaneous Biopsy of the Liver. Tech Vasc Interv Radiol 2021;24:100773. [PMID: 34895710 DOI: 10.1016/j.tvir.2021.100773] [Reference Citation Analysis]
25 Kaufman CS, Cretcher MR. Transjugular Liver Biopsy. Tech Vasc Interv Radiol 2021;24:100795. [PMID: 34895709 DOI: 10.1016/j.tvir.2021.100795] [Reference Citation Analysis]
26 Bang JY, Ward TJ, Guirguis S, Krall K, Contreras F, Jhala N, Navaneethan U, Hawes RH, Varadarajulu S. Radiology-guided percutaneous approach is superior to EUS for performing liver biopsies. Gut 2021;70:2224-6. [PMID: 33766911 DOI: 10.1136/gutjnl-2021-324495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
27 Mendoza YP, Rodrigues SG, Delgado MG, Murgia G, Lange NF, Schropp J, Montani M, Dufour JF, Berzigotti A. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int 2022;42:102-11. [PMID: 34821035 DOI: 10.1111/liv.15116] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
28 Flisiak R, Antonov K, Drastich P, Jarcuska P, Maevskaya M, Makara M, Puljiz Ž, Štabuc B, Trifan A. Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. J Clin Med 2021;10:5419. [PMID: 34830701 DOI: 10.3390/jcm10225419] [Reference Citation Analysis]
29 Zhong C, Jin J, Wang X, Huang Y, Yan D, Wang W. Effects of Different Recovery Positions on the Postpercutaneous Liver Biopsy Complications: A Metaanalysis. Front Surg 2021;8:707945. [PMID: 34778353 DOI: 10.3389/fsurg.2021.707945] [Reference Citation Analysis]
30 Langford CR, Goldinger MH, Treanor D, McGenity C, Dillman JR, Allende DS, Goldin R, Brunt EM, Zatloukal K, Denk H, Fleming KA. Improved pathology reporting in NAFLD/NASH for clinical trials. J Clin Pathol 2021:jclinpath-2021-207967. [PMID: 34753791 DOI: 10.1136/jclinpath-2021-207967] [Reference Citation Analysis]
31 Pavic T, Mikolasevic I, Kralj D, Blazevic N, Skrtic A, Budimir I, Lerotic I, Hrabar D. Role of Endoscopic Ultrasound in Liver Disease: Where Do We Stand? Diagnostics (Basel) 2021;11:2021. [PMID: 34829368 DOI: 10.3390/diagnostics11112021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Murgia A, Ahmed Y, Sweeney K, Nicholson-Scott L, Arthur K, Allsworth M, Boyle B, Gandelman O, Smolinska A, Ferrandino G. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases. Biomedicines 2021;9:1563. [PMID: 34829792 DOI: 10.3390/biomedicines9111563] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep 2021;3:100322. [PMID: 34693236 DOI: 10.1016/j.jhepr.2021.100322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
34 Finer N. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes Obes Metab 2021. [PMID: 34622555 DOI: 10.1111/dom.14569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Behairy BE, Allam AAE, Hegazy SG, Taie DM, Sira AM. Adequacy criteria of Tru-cut needle liver biopsy in neonatal cholestasis. Ann Hepatol 2021;:100548. [PMID: 34600141 DOI: 10.1016/j.aohep.2021.100548] [Reference Citation Analysis]
36 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]
37 McKay A, Pantoja C, Hall R, Matthews S, Spalding P, Banerjee R. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. J Patient Rep Outcomes 2021;5:89. [PMID: 34508298 DOI: 10.1186/s41687-021-00363-5] [Reference Citation Analysis]
38 Zhong J, Allard R, Hewitson D, Weston M, Hulson O, Burbidge S, Lambie H, Kaye T, Wyatt JI, Albazaz R. A real-world study evaluating ultrasound-guided percutaneous non-targeted liver biopsy needle failures and pathology sample-quality assessment in both end-cut and side-notch needles. Br J Radiol 2021;94:20210475. [PMID: 34289324 DOI: 10.1259/bjr.20210475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Mishra S, Bush N, Rana SS. EUS-Guided versus Percutaneous Image-Guided Liver Biopsy: A Battle for Supremacy! Journal of Digestive Endoscopy 2021;12:120-4. [DOI: 10.1055/s-0041-1731865] [Reference Citation Analysis]
40 Cerda Reyes E, González-Navarro EA, Magaz M, Muñoz-Sánchez G, Diaz A, Silva-Junior G, Triguero A, Lafoz E, Campreciós G, Orts L, Perez-Campuzano V, Seijo S, Rubio L, Turon F, Baiges A, Hernández-Gea V, Álvarez-Larran A, Juan M, Garcia-Pagan JC. Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology. Liver Int 2021;41:2171-8. [PMID: 34173316 DOI: 10.1111/liv.14997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Facciorusso A, Ramai D, Conti Bellocchi MC, Bernardoni L, Manfrin E, Muscatiello N, Crinò SF. Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel) 2021;13:3062. [PMID: 34205389 DOI: 10.3390/cancers13123062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
44 Feldman AG, Squires JE, Hsu EK, Lobritto S, Mohammad S; SPLIT Education Committee, the Pediatric Transplant Hepatology Fellowship Program Directors. The current state of pediatric transplant hepatology fellowships: A survey of recent graduates. Pediatr Transplant 2021;:e14065. [PMID: 34120405 DOI: 10.1111/petr.14065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Asai A, Yokohama K, Ohama H, Tsuchimoto Y, Fukunishi S, Higuchi K. Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases. J Clin Med 2021;10:2527. [PMID: 34200283 DOI: 10.3390/jcm10112527] [Reference Citation Analysis]
46 Seth S, Forrest EH, Morris JM, Heydtmann M, Konanahalli P, Kohnen G, Oien KA. Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management. J Clin Pathol 2021:jclinpath-2020-207366. [PMID: 34039666 DOI: 10.1136/jclinpath-2020-207366] [Reference Citation Analysis]
47 Scharf RE. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. J Clin Med 2021;10:1530. [PMID: 33917431 DOI: 10.3390/jcm10071530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
48 Chen H, Dai S, Fang Y, Chen L, Jiang K, Wei Q, Ding K. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Front Oncol 2021;11:631943. [PMID: 33767997 DOI: 10.3389/fonc.2021.631943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Scicali R, Di Pino A, Urbano F, Ferrara V, Marchisello S, Di Mauro S, Scamporrino A, Filippello A, Rabuazzo AM, Purrello F, Piro S. Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience. Nutrition, Metabolism and Cardiovascular Diseases 2021;31:869-79. [DOI: 10.1016/j.numecd.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
50 Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2021;:1-10. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Cho SJ, Perito ER, Shafizadeh N, Kim GE. Dialogs in the assessment of neonatal cholestatic liver disease. Hum Pathol 2021;112:102-15. [PMID: 33359238 DOI: 10.1016/j.humpath.2020.12.007] [Reference Citation Analysis]
52 Borro P, Ziola S, Pasta A, Trombini M, Labanca S, Marenco S, Solarna D, Pisciotta L, Baldissarro I, Picciotto A, Dellepiane S. Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis. Ultrasound Med Biol 2021;47:947-59. [PMID: 33451815 DOI: 10.1016/j.ultrasmedbio.2020.12.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Chetwood JD, Mudaliar S, Staudenmann D, Shin JS, Liu K, Majumdar A, Kaffes A, Strasser S, McCaughan GW, Saxena P. Emerging role of endoscopic ultrasound-guided liver biopsy. Gut 2020:gutjnl-2020-322704. [PMID: 32948619 DOI: 10.1136/gutjnl-2020-322704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]